This study revealed for the first time the venomic proteomes of the large-eyed pit viper (*Trimeresurus macrops*) and Hagen's pit viper (*T. hageni*). Both snakes are widespread across Thailand and Southeast Asia. We quantitatively analyzed different protein clusters from these venoms. The cellular toxicity of the venoms on human fibroblasts and monocytes was also investigated.

1. Introduction {#sec1-toxins-12-00054}
===============

Venomous pit vipers are snakes of the Crotalinae subfamily, characterized by two movable fangs and heat-sensing pit organs located bilaterally between the eye and nostril. *Trimeresurus* is a prominent pit viper genus and comprises the greatest number of known species \[[@B1-toxins-12-00054]\]. *Trimeresurus* snakes are endemic to Asia; they are widely distributed, ranging from deserts to rainforests and in terrestrial, arboreal, and aquatic habitats. *Trimeresurus* bite victims have been reported in several geographic regions, including Lao PDR \[[@B2-toxins-12-00054]\], Hong Kong \[[@B3-toxins-12-00054]\], Taiwan \[[@B4-toxins-12-00054]\], Thailand \[[@B5-toxins-12-00054]\], China \[[@B6-toxins-12-00054]\], Sri Lanka \[[@B7-toxins-12-00054]\], and Japan \[[@B8-toxins-12-00054]\]. In addition, green pit vipers were responsible for 58% of snakebites reported in Vietnam in 2017 \[[@B9-toxins-12-00054]\]. *Trimeresurus* venom varies in toxicity between species; prolonged clotting time is a significant symptom observed in humans \[[@B10-toxins-12-00054]\], and tissue damage and hematotoxicity in bite victims have also been reported \[[@B11-toxins-12-00054],[@B12-toxins-12-00054]\]. Since there is no species-specific antivenom available for *Trimeresurus*, except *T. albolabris*, the only treatment available for bite cases has been a hetero-specific antivenom \[[@B13-toxins-12-00054]\]. Antivenoms raised in horses are the most common therapeutic agents for snakebite treatment; however, they can cause several side effects, such as anaphylactic shock and serum sickness \[[@B14-toxins-12-00054]\]. Moreover, preparation of antivenom from horse blood is laborious and time-consuming with a low production yield \[[@B15-toxins-12-00054]\]. According to proteomics studies, each specific venom contains a unique variety of toxins \[[@B16-toxins-12-00054]\]. To date, *T. insularis* (Indonesian), *T. borneensis* (Borneo), *T. stejnegeri* (Taiwan), *T. puniceus* (Java), *T. purpureomaculatus* (Thailand), *T. gramineus* (India), *T. nebularis* (Malaysia), and *T. alborabris* (Thailand) have been investigated for their venom constituents \[[@B17-toxins-12-00054],[@B18-toxins-12-00054],[@B19-toxins-12-00054]\]. However, there is no reported information on the venomic protein profile of the Southeast Asia endemic species *T. macrops* and *T. hageni*.

The large-eyed pit viper *T. macrops* can be distinguished from other green pit vipers by its relatively large eyes ([Figure 1](#toxins-12-00054-f001){ref-type="fig"}a). *T. macrops* bites frequently cause severe tissue damage in humans with the symptoms ranging from local swelling to severe systemic bleeding \[[@B20-toxins-12-00054]\]. Its venom has a long half-life and can be retained within the human body for more than 14 days \[[@B21-toxins-12-00054]\]. *T. hageni*, known as Hagen's pit viper is also endemic to Southeast Asia ([Figure 1](#toxins-12-00054-f001){ref-type="fig"}b); however, there are only a few reports of the major symptoms of *T. hageni* venom. In addition, no *T. macrops* or *T. hageni* species-specific antivenoms are available. The antivenom raised from *T. albolabris* is currently used for neutralizing *T. macrops* and *T. hageni* venoms. In our study, a comparative proteomics approach was applied to the study of *T. macrops* and *T. hageni* venom protein composition. Moreover, we assessed the cytotoxicity of *T. macrops* and *T. hageni* venoms on monocytic cells (U937 cells) and skin fibroblasts (CRL-1474 cells) to clarify the effects on cellular physiology. The findings facilitate the analysis of cross-reactivity between these snake toxins and the available antivenoms. The identified toxins may be used for the development of inhibitory or neutralizing agents using molecular techniques to improve snakebite treatment. In addition, some proteins with beneficial activities could be further developed as novel pharmacological agents for human disease.

2. Results {#sec2-toxins-12-00054}
==========

2.1. Proteomics Analysis of T. macrops and T. hageni Venom {#sec2dot1-toxins-12-00054}
----------------------------------------------------------

After preparing venom from *T. macrops* and *T. hageni*, the proteins were separated on 12% sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) ([Figure 2](#toxins-12-00054-f002){ref-type="fig"}). Bands at 15, 25, 35, 50, and 55 kDa were the most abundant in *T. macrops* venom. Whereas, bands at 15, 16, 20, 22, 32, 55, and 66 kDa were the most intense in *T. hageni* venom. Each gel lane was excised into 10 pieces. Peptides were extracted from the gel by in-gel digestion and further subjected to liquid chromatography--mass spectrometry (LC-MS/MS) analysis. After MASCOT searching against NCBI (Taxonomy: Chordata), the results revealed that the *T. macrops* and *T. hageni* venoms contained 185 and 216 proteins, respectively ([Supplementary Table S1](#app1-toxins-12-00054){ref-type="app"}). The identified proteins were classified according to their gene ontology, including molecular function, biological process, and cellular component terms ([Table 1](#toxins-12-00054-t001){ref-type="table"}).

In terms of molecular function, most *T. macrops* (75%) and *T. hageni* (44.4%) venom proteins were involved in catalytic activity. Structural molecule activity proteins were observed only in *T. macrops* venom and represented 12.5% of the proteins. Whereas, molecular function regulators comprised 22.2% of *T. hageni* venom proteins. In terms of biological processes, proteins involved in biological regulation and cellular processes were the largest classes present in *T. macrops* (36.4%) and *T. hageni* (26.7%) venoms, respectively. While immune system process, response to stimulus, and localization proteins were found only in *T. hageni* venom. In terms of cellular processes, organelle proteins were found in both *T. macrops* (37.5%) and *T. hageni* (50%) venoms. Whereas, membrane and protein-containing complex molecules were presented only in *T. macrops* venom. Phospholipase A2 (PLA2), snake venom serine protease (SVSP), cysteine-rich secretory, snake venom metalloproteinase (SVMP), disintegrin, L-amino acid oxidase, and C-type lectin were common to the two snake venoms. These protein families contribute to the phenotypic effects of venom on victims. Therefore, all identified proteins were also classified according to the common properties of snake venom, as shown in [Figure 3](#toxins-12-00054-f003){ref-type="fig"}. PLA2, SVSP, cysteine-rich secretory, SVMP, and disintegrin were more abundant in *T. macrops* venom. Whereas, L-amino acid oxidase and C-type lectin were more abundant in *T. hageni* venom. Due to protein semi-quantification, the exponentially modified protein abundance index (emPAI) was used to estimate the amount of proteins. The 20 most abundant proteins in *T. macrops* and *T. hageni* venoms are displayed in [Table 2](#toxins-12-00054-t002){ref-type="table"} and [Table 3](#toxins-12-00054-t003){ref-type="table"}, respectively.

2.2. Cellular Toxicity of T. macrops and T. hageni Venoms on U937 Monocytic Cells and CRL-1474 Skin Fibroblasts {#sec2dot2-toxins-12-00054}
---------------------------------------------------------------------------------------------------------------

At the physiological level, *Trimeresurus* venoms possess a hematotoxic effect; however, the influence of these venoms at the cellular level on immunopotent, blood-inhabited mononuclear cells remains unknown. The cytotoxic effects of *T. macrops* and *T. hageni* venoms on U937 monocytes was examined using the 3-(4,5-dimethyl thiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay ([Figure 4](#toxins-12-00054-f004){ref-type="fig"}). There was no remarkable cytotoxic of *T. macrops* venom on U937 cells ([Figure 4](#toxins-12-00054-f004){ref-type="fig"}a,b). Monocytic cells seemed to be more susceptible to *T. hageni* than *T. macrops* venoms, as a sharp decrease in viable cells could be detected at 24 h for 0.5 mg/mL (*p* \< 0.001) ([Figure 4](#toxins-12-00054-f004){ref-type="fig"}c). The cytotoxicity increased as the concentration of *T. hageni* venom increased, indicating a concentration-dependent action. In addition, a similar toxicity pattern was found when U937 cells were exposed to this species' venom for 72 h, and the LC~50~ values of *T. hageni were* 0.66 and 0.90 mg/mL at 48 and 72 h, respectively.

Because skin is the first organ to encounter the venom after a snakebite and severe dermal tissue damage is frequently reported for *Trimeresurus* cases, the effects of these pit viper venoms on skin fibroblasts were investigated ([Figure 5](#toxins-12-00054-f005){ref-type="fig"}). In comparison with monocytic cells, fibroblasts were more sensitive to both *T. macrops* and *T. hageni* venoms. Fibroblast cell viability substantially reduced after exposure to 0.1 mg/mL of *T. macrops* at 48 h (*p* \< 0.05), and the decline persisted as the concentration of venom increased ([Figure 5](#toxins-12-00054-f005){ref-type="fig"}a), and there was a comparable cytotoxicity at 72 h ([Figure 5](#toxins-12-00054-f005){ref-type="fig"}a,b). LC~50~ values of *T. macrops* were 0.23 mg/mL at both 48 and 72 h. Compared with *T. macrops*, *T. hageni* venom showed negligible toxicity to fibroblasts. ([Figure 5](#toxins-12-00054-f005){ref-type="fig"}c,d). Concerning the relatively high LC~50~ doses, it should be considered that crude venom have been used in these experiments and that there is possible low synergic biological effects among the enzymes and other proteins in the venom of both snakes.

3. Discussion {#sec3-toxins-12-00054}
=============

The protein patterns differed between *T. macrops* and *T. hageni* venoms, which was indicative of the non-identical protein composition of the two venoms. *T. macrops* and *T. hageni* venoms also demonstrated different protein patterns from *T. borneensis, T. gramineus*, *T. puniceus*, *T. purpureomaculatus*, *T. stejnegeri*, and *Protobothrops flavoviridis* \[[@B22-toxins-12-00054]\]. All proteins of both venoms were classified according to their gene ontologies. In terms of molecular function, proteins involved in catalytic activity were the most abundant in both venoms, which corroborates the gene ontology analysis of platypus venom \[[@B23-toxins-12-00054]\]. This protein class includes hemolytic and proteolytic proteins that play important roles during prey acquisition. The main functions of snake venom are to lubricate and immobilize prey. Several protein families have been found to be common in snake venoms, including phospholipase, serine protease, cysteine-rich secretory, metalloproteinase, disintegrin, L-amino acid oxidase, and c-type lectin. Our data show that in *T. hageni* venom, the abundance of proteins of the phospholipase, serine protease, metalloproteinase, disintegrin, L-amino acid oxidase, and c-type lectin families was higher than in *T. macrops* venom. However, no cysteine-rich secretory proteins were observed in *T. hageni* venom.

The two snake species produce biologically active substances in their venom capable of weakening prey to facilitate their capture. Phospholipase can hydrolyze glycerophospholipids to fatty acids and other lipophilic compounds \[[@B24-toxins-12-00054]\]. This protein family from dangerous snake venoms has been reported to affect the peripheral neuromuscular system \[[@B25-toxins-12-00054]\]. In addition, purified phospholipase A2 originating from various snake venoms have been shown to possess anticoagulant properties \[[@B26-toxins-12-00054]\]. *Agkistrodon halys blomhoffii* \[[@B27-toxins-12-00054]\] and *A. palas* \[[@B28-toxins-12-00054]\] phospholipase A2 show antibacterial activity. The acidic phospholipase A2 5 (gi\|13959432), acidic phospholipase A2 6 (gi\|20177994), and basic phospholipase A2 2 (gi\|13959429) were one of the twenty most abundant proteins in *T. macrops* crude venom. While, acidic phospholipase A2 2 (gi\|3914268), acidic phospholipase A2 5 (gi\|13959432), basic phospholipase A2 homolog Ts-R6 (gi\|82201344), acidic phospholipase A2 1 (gi\|129417), and D1E6b phospholipase A2 (gi\|59727030) were among the 20 most abundant proteins in *T. hageni* crude venom. Although phospholipases were abundance proteins identified in both *T. macrops* and *T. hageni.* Their biological activities such as neuromuscular, anticoagulant, and antibacterial require further experiment for characterization.

Serine proteases have been reported to effect blood coagulation systems, e.g., the fibrinolytic system \[[@B29-toxins-12-00054]\]. Some venom serine proteases are not susceptible to hirudin, heparin, or the most endogenous serine protease inhibitors. A few venom serine proteases can activate coagulation factor V, protein C, plasminogen, and platelets \[[@B30-toxins-12-00054]\]. Snake venom serine protease 2B (gi\|13959619) and snake venom serine protease 1 (gi\|13959617) were found in abundant proportions in *T. macrops* and *T. hageni* crude venoms, respectively, and similarly to serine proteases of other snake venoms, they may disturb prey blood coagulation, resulting in severe bleeding. Venom metalloproteinases are also exceedingly toxic; these enzymes interfere with blood coagulation and hemostatic plug formation and destroy cell membranes and the extracellular matrix \[[@B31-toxins-12-00054]\]. Snake venom metalloproteinase (gi\|123894851) was abundant in *T. macrops* crude venom and may fulfil the same role as in other snake venoms.

Disintegrins are cysteine-rich peptides ranging from 45 to 84 amino acids in length and are non-enzymatic proteins found in the venom of numerous snake families. Their influence on platelet aggregation and integrin-dependent cell adhesion has been reported \[[@B32-toxins-12-00054]\]. The proteolysis resistance of these proteins results in a sustained half-life in the blood of prey \[[@B33-toxins-12-00054]\]. Disintegrin trigramin-gamma (gi\|67462321) was predominantly found in *T. macrops* crude venom and plays a similar role as in other snake venoms. L-amino acid oxidase accelerates the oxidation of amino acids \[[@B34-toxins-12-00054]\] and can cause plasma clotting disorders as well as inducing apoptosis in various cell lines \[[@B35-toxins-12-00054]\]. L-amino acid oxidase was found in high concentrations in *T. macrops* and *T. hageni* and may contribute to the toxicity of the venoms. C-type lectin protein is a non-enzymatic, calcium dependent protein that binds sugar residues \[[@B36-toxins-12-00054]\]. Many snake venom c-type lectin-like proteins target coagulation factors \[[@B37-toxins-12-00054]\]. The Southeast Asian *T. albolabris* c-type lectin protein binds directly to the von Willebrand factor receptor, which has key functions in both the hemostatic and thrombotic pathways, leading to platelet agglutination \[[@B38-toxins-12-00054]\]. In contrast, c-type lectin protein found in the Asian viper *Echis carinatus* inhibits platelet agglutination \[[@B39-toxins-12-00054]\]. C-type lectin-like proteins were found in *T. macrops* and *T. hageni* venoms and may have similar functions in blood coagulation and platelet activation.

Cysteine-rich secretory protein is a single-chain bioactive polypeptide identified in several organisms, including snakes \[[@B40-toxins-12-00054]\], reptiles \[[@B41-toxins-12-00054]\], and mammals \[[@B42-toxins-12-00054]\]. Snake venom cysteine-rich secretory protein can block smooth muscle contraction by blocking l-type calcium channels \[[@B43-toxins-12-00054]\]. Moreover, this protein inhibits cyclic nucleotide-gated ion channels, which are significant in various sensory pathways, including vision and olfaction, as well as in other key cellular functions, such as hormone release and chemotaxis \[[@B44-toxins-12-00054]\]. The cysteine-rich secretory protein family was identified in *T. hageni*, but not *T. macrops*, venom. The biological activity of these proteins may include effects on prey vision and olfaction.

Several studies have demonstrated the cytotoxicity of crude snake venom on human cell lines using in vitro assays, e.g., *Lachesis muta* venom on keratinocytes \[[@B45-toxins-12-00054]\], and *Ophiophagus hannah* and *Echis carinatus* on pancreatic tumor cells \[[@B46-toxins-12-00054]\]. Both *T. macrops* and *T. hageni* showed cytotoxicity towards human monocytes and skin fibroblasts. However, the latter exhibited a greater sensitivity to both *Trimeresurus* venoms, indicating a greater abundance of molecular targets for proteolytic enzymes. In addition, Foxo-3-mediated oxidative stress DNA damage leading to cellular senescence was recently reported in fibroblasts exposed to non-lethal doses of *Naja siamensis*, *Naja melanoleuca*, and *Dendroaspis viridis* venoms \[[@B47-toxins-12-00054]\]. Such effects could also be stimulated by pit viper venoms.

There is an agreement between the monocyte toxicity and the proteomics results, as *T. hageni* contained more venomous biological substances, and the venom contained members of the cysteine-rich secretory protein family. Indeed, the discrepancy in fibrinogen pseudo-procoagulant clotting potency and Green Pit Viper antivenom neutralization efficacy between *T. macrops* and *T. hageni* was recently revealed \[[@B48-toxins-12-00054]\], reflecting the fundamental evolutionary differences among the different *Trimeresurus* species. An in-depth study of other relevant physiologic effects would be beneficial in the continuing characterizations of the clinical effects of *T. macrops* and *T. hageni* venoms. The information would also facilitate the use of antivenom for treating bite victims. In addition, some venom components may be useful in the development of novel therapeutic agents for human diseases.

4. Materials and Methods {#sec4-toxins-12-00054}
========================

4.1. Venom Collection {#sec4dot1-toxins-12-00054}
---------------------

The study has been reviewed and approved by the committee in accordance with Queen Saovabha Memorial Institute regulations and policies governing the care and use of laboratory animals (QSMI-ACUC-01-2018). The venoms of *T. macrops* and *T. hageni* were extracted from individual snakes and kept in a 1.5 mL microcentrifuge tubes. After being weighed, the fresh (liquid) venoms were immediately frozen at −20 °C and lyophilized. The dry (lyophilized) venoms were pooled (from at least three snakes) and stored at −20 °C for use in this study.

4.2. T. macrops and T. hageni Venom Protein Separation {#sec4dot2-toxins-12-00054}
------------------------------------------------------

Crude venoms of *T. macrops* and *T. hageni* were mixed with lysis buffer (containing 1% Triton X-100 (Merck, Germany), 1% sodium dodecyl sulfate (SDS) (Merck, Darmstadt, Germany), and 1% NaCl (Merck, Germany). The venoms were analyzed for their estimated protein concentration by Quick Start™ Bradford Protein Assay (Bio-Rad, Berkeley, CA, USA). A 30 µg sample of *T. macrops* and *T. hageni* venom solutions were separated by 12% SDS-PAGE (Bio-Rad, CA, USA) and stained by Coomassie R-250 solution (Bio-Rad, CA, USA). A whole lane of each venom was excised into 10 pieces and further subjected to in-gel digestion.

4.3. In-Gel Digestion {#sec4dot3-toxins-12-00054}
---------------------

A 50% acetonitrile (ACN) in 50 mM ammonium bicarbonate solution was used for destaining the blue color from gel slides. Venom proteins were reduced by 4 mM dithiothreitol and incubated at 60 °C for 15 min. The reduced proteins were further alkylated by 250 mM iodoacetamine (Sigma-Aldrich, Saint Louis, MO, USA) and incubated at room temperature for 30 min in the dark. The gel pieces were dehydrated by removing all solution and adding 100% ACN (Thermo Scientific, Waltham, MA, USA). For tryptic digestion, trypsin (Sigma-Aldrich, USA, T6567) in 50 mM ammonium bicarbonate (Sigma-Aldrich, USA) was added to rehydrate the gels and incubated overnight at 37 °C. The peptide was extracted by adding 100% ACN and incubating for 15 min. The solution was transferred into a new microcentrifuge tube and dried using centrifugal concentrator (TOMY, Katsushika, Japan). The peptide mixtures were stored at −20 °C prior to mass spectrometric (MS) analysis.

4.4. Mass Spectrometric Analysis {#sec4dot4-toxins-12-00054}
--------------------------------

Venom peptides were dissolved in 0.1% formic acid (Sigma-Aldrich, USA) and subjected to an Ultimate^®^ 3000 Nano-LC system analysis (Thermo Scientific, USA). The peptides were eluted and infused with a microTOF-Q II (Bruker, Bremen, Germany). The acquisition was operated by HyStar™ version 3.2 (Bruker, Germany). The data were processed and converted to mascot generics files (.mgf) using Compass DataAnalysis™ software version 3.4 (Bruker, Germany). The database search was performed using Mascot Daemon software (Matrix Science, Boston, MA, USA) against Chordata NCBI database with the following parameters: one missed cleavage site, variable modifications of carbamidomethyl (C) and oxidation (M), 0.8 Da for MS peptide tolerance, and 0.8 Da for MS/MS tolerance. The significance threshold was set at 95%. Three biological replications were performed for protein identification. The obtained proteins were classified according to their gene ontology using Blast2Go software.

4.5. Cell Culture {#sec4dot5-toxins-12-00054}
-----------------

Human monocytic cells (U937 cell line from CLS cell line service) and normal human skin fibroblast cell line (CRL-1474 from ATCC) were cultured in RPMI 1640 (Invitrogen, Carlsbad, CA, USA) and D-MEM (Invitrogen), respectively. Media were supplemented with 10% fetal calf serum (Sigma-Aldrich, Saint Louis, MO, USA), 2 mM L-glutamine, penicillin (100 units/mL), and streptomycin (100 µg/mL). The cells were incubated in 5% CO~2~ at 37 °C and sub-cultured every 3 days. The morphology was monitored under an inverted microscope (CX1 Olympus, Tokyo, Japan).

4.6. Venom Cytotoxicity on Monocytic Cell (U937 Cell) and Skin Fibroblasts (CRL-1474) {#sec4dot6-toxins-12-00054}
-------------------------------------------------------------------------------------

U937 cells at a density of 2.5 × 10^5^ cells/mL and fibroblasts at 105 cells/mL were seeded into a well of 96-well plate and cultured for 24 h. The solution was discarded from each well. *T. macrops* and *T. hageni* crude venoms were added to U937 cells (at concentration ranging from 0 to 3 mg/mL), and fibroblasts (at concentration ranging from 0 to 0.5 mg/mL) and further incubated for 48 and 72 h. To examine cell viability, 10 µL of 5 mg/mL MTT was added to each well. The reaction was incubated in 5% CO~2~ at 37 °C for 4 h. The absorbance of formazan product was measured at 570 nm by an Infinite M200 PRO microplate reader (Tecan, Mannedorf, Switzerland). The percentage of cell viability was calculated relative to the untreated control cells.

4.7. Statistical Analysis {#sec4dot7-toxins-12-00054}
-------------------------

Quantitative data are presented as mean ± SEM. Statistical significance between groups was analyzed using standard t-tests or two-way ANOVA followed by the Bonferroni test. Significant *p*-values are indicated within the figure panels. Error bars indicate SEM.
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![Two prominent species of *Trimeresurus* snakes in Thailand. Adult large-eyed pit viper (*T. macrops*) with its noticeably large eyes (**a**) and the Hagen's pit viper (*T. hageni*) perching on a tree branch (**b**).](toxins-12-00054-g001){#toxins-12-00054-f001}

![Coomassie blue-stained 12% sodium dodecyl sulfate polyacrylamide gel electrophoresis of *T. macrops* and *T. hageni* venoms (30 µg) under reducing conditions.](toxins-12-00054-g002){#toxins-12-00054-f002}

![Proteome classification of *T. macrops* (blue) and *T. hageni* (orange) venoms; proteomes were classified according to common functions of snake venom.](toxins-12-00054-g003){#toxins-12-00054-f003}

![Cytotoxicity of *Trimeresurus macrops* and *T. hageni* venoms on human monocytic cells determined by 3-(4,5-dimethyl thiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay. U937 cells were treated with 0 to 3 mg/mL *T. macrops* venom for 48 (**a**) and 72 h (**b**) or with 0 to 3 mg/mL of *T. hageni* venom for 48 (**c**) and 72 h (**d**). Percentage U937 cell viability of venom-treated compared with non-venom treated cells (control). Data represent the mean ± standard error of mean (SEM) from three independent experiments, \*\* *p* \< 0.01, \*\*\* *p* \< 0.001.](toxins-12-00054-g004){#toxins-12-00054-f004}

![Cytotoxicity of Trimeresurus *macrops* and *T. hageni* venoms on human skin fibroblasts determined by 3-(4,5-dimethyl thiazol-2-yl)-2,5-diphenyl tetrazolium bromide assay. CRL-1474 skin fibroblasts were treated with 0 to 0.3 mg/mL *T. macrops* venom for 48 (**a**) and 72 h (**b**) or with 0 to 0.5 mg/mL *T. hageni* venom for 48 (**c**) and 72 h (**d**). Percentage CRL-1474 fibroblast cell viability of venom-treated compared with non-venom treated cells (control). Data represent the mean ± standard error of mean (SEM) from two independent experiments, \* *p* \< 0.05, \*\* *p* \< 0.01 and \*\*\* *p* \< 0.001.](toxins-12-00054-g005){#toxins-12-00054-f005}

toxins-12-00054-t001_Table 1

###### 

Gene ontology classification of *Trimeresurus macrops* and *T. hageni* crude venom proteins.

  Gene Ontology                               \% of Protein Components   
  ------------------------------------------- -------------------------- ------
  Molecular Function                                                     
  binding (GO:0005488)                        12.5                       33.3
  catalytic activity (GO:0003824)             75.0                       44.4
  structural molecule activity (GO:0005198)   12.5                       \-
  molecular function regulator (GO:0098772)   \-                         22.2
  Biological Process                                                     
  biological regulation (GO:0065007)          36.4                       20.0
  cellular process (GO:0009987)               27.3                       26.7
  metabolic process (GO:0008152)              9.1                        6.7
  rhythmic process (GO:0048511)               27.3                       20.0
  immune system process (GO:0002376)          \-                         6.7
  response to stimulus (GO:0050896)           \-                         6.7
  localization (GO:0051179)                   \-                         13.3
  Cellular component                                                     
  cell (GO:0005623)                           25.0                       33.3
  extracellular region (GO:0005576)           12.5                       16.7
  membrane (GO:0016020)                       12.5                       \-
  organelle (GO:0043226)                      37.5                       50.0
  protein-containing complex (GO:0032991)     12.5                       \-

toxins-12-00054-t002_Table 2

###### 

Top-20 unique proteins identified in *T. macrops* crude venom.

  No.   Accession No.   Protein                                             Family                  Score   M.W.     No. of Peptide   \% Sequence Coverage   pI      emPAI
  ----- --------------- --------------------------------------------------- ----------------------- ------- -------- ---------------- ---------------------- ------- -------
  1     gi\|299493      Thrombin-like proteinase                            Protease                99      2737     2                54.2                   4.31    4.69
  2     gi\|46395675    Cysteine-rich venom protein tripurin                Toxin activity          86      3971     2                33.3                   9.19    2.76
  3     gi\|13959432    Acidic phospholipase A2 5                           Toxin activity          442     13,870   4                27.9                   4.72    2.74
  4     gi\|67462321    Disintegrin trigramin-gamma                         Protease                111     7568     2                28.8                   4.61    2.17
  5     gi\|697351484   Chain A, crystal structure of an acidic Pla2        Toxin activity          443     13,710   4                36.4                   4.81    2.03
  6     gi\|60593434    Chain A, crystal structure of stecrisp              Toxin activity          238     25,112   4                18.1                   5.53    1.12
  7     gi\|20177994    Acidic phospholipase A2 6                           Toxin activity          146     15,712   3                21                     4.72    0.79
  10    gi\|538259813   Galactose binding lectin, partial                   CHO binding             79      17,654   3                23                     5.72    0.69
  11    gi\|3552036     Pallase                                             Protease                151     26,162   3                19.4                   5.89    0.62
  12    gi\|344268956   Phorbol-12-myristate-13-acetate-induced protein 1   Apoptotic process       36      6008     1                12.7                   10.06   0.60
  14    gi\|13959429    Basic phospholipase A2 2                            Toxin activity          130     7813     1                14.3                   8.49    0.45
  15    gi\|82094948    Bradykinin-releasing enzyme KR-E-1                  Protease                102     25,335   3                13.2                   4.82    0.45
  16    gi\|123894851   Snake venom metalloproteinase                       Protease                364     68,673   7                12.2                   6.4     0.39
  17    gi\|13959619    Snake venom serine protease 2B                      Protease                71      28,915   3                17.3                   5.54    0.39
  18    gi\|538259847   5'-nucleotidase                                     Nucleotidase activity   203     57,055   7                15.1                   8.27    0.32
  19    gi\|32469800    Thrombin-like enzyme contortrixobin                 Protease                102     25,396   3                13.2                   4.95    0.28
  20    gi\|143681919   Thrombin-like enzyme kangshuanmei                   Protease                99      26,415   2                14.8                   8.27    0.27
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###### 

Top-20 unique identified proteins from *T. hageni* crude venom.

  No.   Accession No.   Protein                                                                                                Family                         Score   M.W.     No. of Peptides   %Sequence Coverage   pI     emPAI
  ----- --------------- ------------------------------------------------------------------------------------------------------ ------------------------------ ------- -------- ----------------- -------------------- ------ -------
  1     gi\|82130933    Snaclec coagulation factor IX-binding protein subunit A                                                Toxin activity                 145     14,631   4                 31.8                 4.92   1.31
  2     gi\|67462321    Platelet aggregation activation inhibitor                                                              Protease                       162     7568     2                 28.8                 4.61   1.16
  3     gi\|60593434    Chain A, crystal structure of stecrisp                                                                 Toxin activity                 174     25,112   5                 21.7                 5.53   1.12
  4     gi\|3914268     Acidic phospholipase A2 2                                                                              Toxin activity                 155     13,784   4                 38.5                 4.95   0.94
  5     gi\|538259791   C-type lectin factor IX/X binding protein A subunit,                                                   CHO binding                    122     14,688   3                 30                   4.92   0.87
  6     gi\|32469800    Thrombin-like enzyme contortrixobin                                                                    Protease                       450     25,396   6                 18.4                 4.95   0.85
  7     gi\|39655009    Chain A, crystal structure of a platelet agglutination factor isolated from the venom of Taiwan Habu   Protease                       227     15,718   5                 26.7                 5.09   0.79
  8     gi\|126130      Galactose-specific lectin                                                                              CHO binding                    55      16,281   4                 31.1                 5.54   0.76
  9     gi\|565235162   hypothetical protein L345_18387, partial                                                               Unknown                        36      5242     1                 37.5                 3.63   0.7
  10    gi\|13959617    Snake venom serine protease 1                                                                          Protease                       150     27,923   6                 22.5                 5.66   0.57
  11    gi\|13959432    Acidic phospholipase A2 5                                                                              Toxin activity                 65      13,870   2                 11.5                 4.72   0.55
  12    gi\|82201344    Basic phospholipase A2 homolog Ts-R6                                                                   Toxin activity                 56      15,477   5                 24.8                 8.5    0.49
  13    gi\|129417      Acidic phospholipase A2 1                                                                              Toxin activity                 62      15,524   2                 10.1                 6.54   0.48
  14    gi\|356581537   Beta-defensin-like protein 10                                                                          Chemokine receptor binding     14      7492     1                 9                    9.73   0.48
  15    gi\|59727030    D1E6b phospholipase A2                                                                                 Toxin activity                 85      15,959   2                 10.1                 4.79   0.47
  16    gi\|360797      Flavoxobin                                                                                             Protease                       158     25,725   5                 13.6                 5.2    0.44
  17    gi\|538259853   Phosphodiesterase                                                                                      Magnesium binding              128     96,526   15                17                   8.03   0.44
  18    gi\|676251620   Neurofibromin,                                                                                         Phosphatid-ylcholine binding   30      7991     1                 8.6                  8.66   0.44
  19    gi\|538259847   5ʹ-nucleotidase,                                                                                       Nucleotidase activity          177     57,055   10                19.5                 8.27   0.4
  20    gi\|632991866   Transmembrane protein 184B-like                                                                        Unknown                        52      9150     1                 13.1                 5.65   0.37
